Abstract
As microbes use many mechanisms for avoiding immunological pressure, new strategies must be developed to bypass the immunological code of silence of conserved, functionally-important amino acid sequences, such as those involved in high activity binding peptides (HABPs) attaching to their host cells. Hundreds of experiments in large numbers of Aotus monkeys revealed that this immunological code of silence could be broken by shifting the polarity of some critical host cell binding residues in these HABPs by substituting F for R and vice versa, YW, LH, IN, PD, MK or E, CT, VN or S; there are special rules for A, G and S. 1H-nuclear magnetic resonance of these modified, immunogenic, protection-inducing HABPs and molecular modelling revealed that such modifications induced appropriate fitting into specific HLA-DRβ1* Pockets, suggesting the presence of new pockets and a haplotype- and allele-specific conscious TCR. A highly immunogenic and protection-inducing anti-malarial vaccine can thus be produced.
Keywords: Malaria, P. falciparum, 1H-NMR, HLA-DRβ1* molecules, immunogenic peptides
Medicinal Chemistry
Title: Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens Code of Silence
Volume: 4 Issue: 3
Author(s): G. Cifuentes, A. Bermudez, R. Rodriguez, M. A. Patarroyo and M. E. Patarroyo
Affiliation:
Keywords: Malaria, P. falciparum, 1H-NMR, HLA-DRβ1* molecules, immunogenic peptides
Abstract: As microbes use many mechanisms for avoiding immunological pressure, new strategies must be developed to bypass the immunological code of silence of conserved, functionally-important amino acid sequences, such as those involved in high activity binding peptides (HABPs) attaching to their host cells. Hundreds of experiments in large numbers of Aotus monkeys revealed that this immunological code of silence could be broken by shifting the polarity of some critical host cell binding residues in these HABPs by substituting F for R and vice versa, YW, LH, IN, PD, MK or E, CT, VN or S; there are special rules for A, G and S. 1H-nuclear magnetic resonance of these modified, immunogenic, protection-inducing HABPs and molecular modelling revealed that such modifications induced appropriate fitting into specific HLA-DRβ1* Pockets, suggesting the presence of new pockets and a haplotype- and allele-specific conscious TCR. A highly immunogenic and protection-inducing anti-malarial vaccine can thus be produced.
Export Options
About this article
Cite this article as:
Cifuentes G., Bermudez A., Rodriguez R., Patarroyo A. M. and Patarroyo E. M., Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens Code of Silence, Medicinal Chemistry 2008; 4 (3) . https://dx.doi.org/10.2174/157340608784325160
DOI https://dx.doi.org/10.2174/157340608784325160 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alginate Based Nanocarriers for Drug Delivery Applications
Current Pharmaceutical Design Therapeutic Use of Chemokines
Current Pharmaceutical Design Real-time Polymerase Chain Reaction for Mycobacterium tuberculosis Meningitis is More Sensitive in Patients with HIV Co-Infection
Current HIV Research New Insights into Vitamin D and Autophagy in Inflammatory Bowel Diseases
Current Medicinal Chemistry Alternative Nucleophilic Residues in Intein Catalysis of Protein Splicing
Protein & Peptide Letters Hodgkin Lymphoma in HIV Positive Patients
Current HIV Research Anti-Tuberculosis
Current Bioactive Compounds The Interplay of Disease Modifying Anti Rheumatic Drugs and Tuberculin Skin Test
Current Reviews in Clinical and Experimental Pharmacology Calix[n]arenes as Goldmines for the Development of Chemical Entities of Pharmaceutical Interest
Current Pharmaceutical Design Editorial (Thematic Issue: Medicinal Chemistry Studies of Neglected Diseases)
Mini-Reviews in Medicinal Chemistry Plasmacytoid Dendritic Cells Count in Antiretroviral-Treated Patients is Predictive of HIV Load Control Independent of CD4+ T-Cell Count
Current HIV Research Snake Venom Proteins and Peptides as Novel Antibiotics Against Microbial Infections
Current Proteomics Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review
Current Drug Safety Comparative Proteome Analysis of <i>Mycobacterium Tuberculosis</i> Strains - H37Ra, H37Rv, CCDC5180, and CAS/NITR204: A Step Forward to Identify Novel Drug Targets
Letters in Drug Design & Discovery Type II NADH:Menaquinone Oxidoreductase of Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis
Current Drug Targets Antibacterial Activity of Lipophilic Fluoroquinolone Derivatives
Medicinal Chemistry Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery EHDA Spraying: A Multi-Material Nano-Engineering Route
Current Pharmaceutical Design